These findings suggest that icariin inhibits pathological myocardial hypertrophy primarily through the activation of AMPK and the inhibition of mTOR, thereby facilitating autophagy (Hu L. et al., 2022). Here, PRKAA2 is linked to cardiac hypertrophy.